Laila Mahran

932 total citations
28 papers, 727 citations indexed

About

Laila Mahran is a scholar working on Pharmacology, Molecular Biology and Complementary and alternative medicine. According to data from OpenAlex, Laila Mahran has authored 28 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 7 papers in Molecular Biology and 5 papers in Complementary and alternative medicine. Recurrent topics in Laila Mahran's work include Nigella sativa pharmacological applications (5 papers), Analytical Chemistry and Chromatography (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Laila Mahran is often cited by papers focused on Nigella sativa pharmacological applications (5 papers), Analytical Chemistry and Chromatography (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Laila Mahran collaborates with scholars based in Egypt, Germany and Austria. Laila Mahran's co-authors include Hanan M. El-Laithy, Ola A. Heikal, Mohamed T. Khayyal, Nahla Ayoub, Khaled Abou‐Aisha, S Okpanyi, Mona A. El‐Ghazaly, Sanaa A. Kenawy, Heba Handoussa and Nesrine S. El Sayed and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Laila Mahran

28 papers receiving 693 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laila Mahran Egypt 15 212 150 120 96 89 28 727
Sanjay Sharma India 17 243 1.1× 141 0.9× 107 0.9× 99 1.0× 80 0.9× 64 973
Vadivelan Ramachandran India 13 199 0.9× 58 0.4× 91 0.8× 115 1.2× 79 0.9× 55 668
Lasse Saaby Denmark 17 335 1.6× 108 0.7× 103 0.9× 176 1.8× 75 0.8× 39 1.1k
Talha Jawaid Saudi Arabia 17 173 0.8× 53 0.4× 114 0.9× 132 1.4× 96 1.1× 67 703
Suresh Purohit India 12 170 0.8× 127 0.8× 107 0.9× 187 1.9× 63 0.7× 36 639
Çiğdem Yücel Türkiye 13 182 0.9× 89 0.6× 60 0.5× 120 1.3× 78 0.9× 40 635
Shital S. Panchal India 14 122 0.6× 79 0.5× 50 0.4× 109 1.1× 60 0.7× 34 536
Ankita Wal India 13 210 1.0× 46 0.3× 76 0.6× 181 1.9× 69 0.8× 105 714
Ashwini Kumar India 15 262 1.2× 131 0.9× 89 0.7× 112 1.2× 76 0.9× 47 1.1k

Countries citing papers authored by Laila Mahran

Since Specialization
Citations

This map shows the geographic impact of Laila Mahran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laila Mahran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laila Mahran more than expected).

Fields of papers citing papers by Laila Mahran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laila Mahran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laila Mahran. The network helps show where Laila Mahran may publish in the future.

Co-authorship network of co-authors of Laila Mahran

This figure shows the co-authorship network connecting the top 25 collaborators of Laila Mahran. A scholar is included among the top collaborators of Laila Mahran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laila Mahran. Laila Mahran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zaghloul, Ashraf, et al.. (2017). Therapy-relevant aberrant expression of MRP3 and BCRP mRNA in TCC-/SCC-bladder cancer tissue of untreated patients. Oncology Reports. 38(1). 551–560. 3 indexed citations
3.
Watzl, Carsten, et al.. (2017). Altered expression of miR-181a and miR-146a does not change the expression of surface NCRs in human NK cells. Scientific Reports. 7(1). 41381–41381. 7 indexed citations
5.
Mahran, Laila, et al.. (2013). Assessment of the efficacy of polyclonal intravenous immunoglobulin G (IVIG) against the infectivity of clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo. European Journal of Clinical Microbiology & Infectious Diseases. 32(9). 1149–1160. 19 indexed citations
7.
Handoussa, Heba, Rasha S. Hanafi, Mohamed Elgendy, et al.. (2013). Anti-inflammatory and cytotoxic activities of dietary phenolics isolated from Corchorus olitorius and Vitis vinifera. Journal of Functional Foods. 5(3). 1204–1216. 57 indexed citations
8.
Gad, Mohamed Z., et al.. (2012). Changes in ADMA and TAFI levels after stenting in coronary artery disease patients. Molecular Medicine Reports. 6(4). 855–859. 6 indexed citations
9.
Hanafi, Rasha S., H. Spahn‐Langguth, Laila Mahran, et al.. (2012). Computer-Assisted HPLC Method Development for Determination of Tolmetin and Possible Kinetic Modulators of Its Oxidative Metabolism in Vivo. Chromatographia. 75(9-10). 469–477. 4 indexed citations
10.
Abdel‐Haleem, Alyaa M., et al.. (2011). Expression of RFC/SLC19A1 is Associated with Tumor Type in Bladder Cancer Patients. PLoS ONE. 6(7). e21820–e21820. 14 indexed citations
11.
Sayed, Nesrine S. El, et al.. (2011). Anti-asthmatic and Anti-allergic Effects of Thymoquinone on Experimentally-Induced Hypersensitivity. SHILAP Revista de lepidopterología. 1(1). 5 indexed citations
12.
Sayed, Nesrine S. El, Laila Mahran, & Mahmoud M. Khattab. (2011). Tempol, a membrane-permeable radical scavenger, ameliorates lipopolysaccharide-induced acute lung injury in mice: A key role for superoxide anion. European Journal of Pharmacology. 663(1-3). 68–73. 25 indexed citations
13.
Heikal, Ola A., et al.. (2011). Antiapoptotic effect of DDB against hepatic ischemia-reperfusion injury. The Journal of Toxicological Sciences. 36(2). 145–154. 14 indexed citations
14.
Raafat, Karim, Ulrike Breitinger, Laila Mahran, Nahla Ayoub, & Hans‐Georg Breitinger. (2010). Synergistic Inhibition of Glycinergic Transmission In Vitro and In Vivo by Flavonoids and Strychnine. Toxicological Sciences. 118(1). 171–182. 31 indexed citations
15.
El-Laithy, Hanan M., et al.. (2010). Novel sugar esters proniosomes for transdermal delivery of vinpocetine: Preclinical and clinical studies. European Journal of Pharmaceutics and Biopharmaceutics. 77(1). 43–55. 185 indexed citations
16.
El-Kassem, Lamia T. Abou, et al.. (2009). Thymoquinone triggers anti-apoptotic signaling targeting death ligand and apoptotic regulators in a model of hepatic ischemia reperfusion injury.. PubMed. 3(6). 296–306. 49 indexed citations
17.
Handoussa, Heba, et al.. (2009). Spicatic acid: A 4-carboxygentisic acid from Gentiana spicata extract with potential hepatoprotective activity.. PubMed. 3(6). 278–86. 12 indexed citations
18.
Raymon, Lionel P., Laila Mahran, & Mohyee E. Eldefrawi. (1994). Thin Layer Scintillation Counting in Drug-Receptor Binding. Analytical Letters. 27(5). 907–918. 4 indexed citations
19.
Cao, Cheng, et al.. (1989). Putative Cocaine Receptor in Striatum Is a Glycoprotein with Active Thiol Function. PubMed. 8(4). 207–220. 35 indexed citations
20.
Henley, Charles M., Laila Mahran, & Jochen Schacht. (1988). Inhibition of renal ornithine decarboxylase by aminoglycoside antibiotics in vitro. Biochemical Pharmacology. 37(9). 1679–1682. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026